|
US2017296647A1
|
|
Prophylactic protection against viral infections, particularly HIV
|
|
WO2017142807A1
|
|
Treatment or prevention of zika virus infections by administration of a ribonuclease
|
|
US2017157219A1
|
|
Methods of treating zika virus, mers-cov, chikungunya, venezuelan equine encephalitus, and rhinovirus in mammalian patients
|
|
CN107920990A
|
|
Medicine for the viral infection for treating eyes
|
|
US2016045431A1
|
|
Antiviral pharmaceutical for topical administration
|
|
US2015376584A1
|
|
Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
|
|
WO2015148768A2
|
|
Onconase for use in treating or preventing viral infections
|
|
US2016045574A1
|
|
Antiviral pharmaceutical for topical administration
|
|
US2014037610A1
|
|
Methods of treating infections originating from viruses in the herpesviridae family
|
